Food and Drug Administration

U.S. President Joe Biden will nominate industry-friendly Robert Califf to lead FDA

Moderna says FDA needs more time to complete review of its COVID-19 shot for adolescents

FDA approves kids’ COVID-19 vaccine in U.S., Canada likely close behind

FDA panel backs Pfizer’s low-dose COVID-19 vaccine for kids

Pfizer COVID-19 vaccine shows 90.7% efficacy in clinical trial involving children

FDA expected to authorize mix-and-match COVID-19 booster shots

Next on FDA’s agenda: COVID-19 booster shots of Moderna, J&J vaccines

Johnson & Johnson seeks U.S. clearance for COVID-19 vaccine booster doses

Restrictions imposed on Ontario doctor accused of spreading COVID-19 misinformation

Fauci says key data on Moderna, J&J COVID-19 boosters ‘weeks away’

FDA advisory panel backs COVID-19 boosters only for elderly, high-risk

U.S. COVID-19 vaccine approval is ‘seismic’ shift for legality of mandates, experts say

Fauci says U.S. could control COVID-19 by spring 2022 if more people get shots

U.S. FDA grants full approval to Pfizer-BioNTech’s COVID-19 vaccine

U.S. FDA has not seen possible side-effects of COVID-19 shots being studied in EU

Will Canada approve new Alzheimer’s drug? It’s not certain Aducanumab will get green light

FDA investigating how a known carcinogen wound up in Johnson & Johnson sunscreen

Neutrogena sunscreens recalled after carcinogen found in some sprays

FDA wants probe into its approval of Alzheimer’s drug from Biogen

U.S. drug regulator details failures at Baltimore vaccine plant that led to tossing of COVID-19 doses

U.S. will share its supply of AstraZeneca COVID-19 vaccines based on urgent need, pending FDA clearance

A healthier economy: BC’s opportunity to grow a domestic COVID-19 vaccine supply

Johnson & Johnson’s COVID-19 vaccine gets CDC panel backing, nearly ready for shipping

Johnson & Johnson’s one-dose COVID-19 vaccine closes in on U.S. approval

J&J asks U.S. regulators to approve its single-shot COVID-19 vaccine for emergency use

Shares in B.C.’s Aurinia jump more than 25 per cent on FDA approval to sell lupus drug

Rare milestone approaches for Canadian biotech sector as Aurinia awaits FDA OK to sell new drug

FDA clears Moderna COVID-19 vaccine for emergency rollout

U.S. FDA advisory panel sets stage for Moderna vaccine authorization

Over-the-counter home test for COVID-19 gets green light in U.S.

U.S. FDA authorizes Pfizer COVID-19 vaccine for emergency use

U.S. panel endorses widespread use of Pfizer COVID-19 vaccine